Emyria in ‘final stages’ of winding down Emerald Clinics by Steve Jones September 3, 2024September 3, 2024 Emyria is winding down its cannabis clinic business to focus on MDMA-assisted therapy as its chief […]
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Two-year study of 4,000 patients reveals cannabis is ‘safe and efficacious’ by Steve Jones November 23, 2022April 29, 2024
We need to talk about flower – the vexing challenge of dried cannabis by Steve Jones September 21, 2022April 29, 2024
We’re coming for you, TGA warns rule-breaking clinics after issuing 32 cease and desist orders by Steve Jones July 15, 2021April 26, 2024
New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment by Martin Lane June 10, 2021April 26, 2024
Emyria and Cann Group ink deal to fast track over-the-counter CBD registration by Martin Lane March 29, 2021April 26, 2024
